Abstract
Infection with Strongyloides stercoralis is a significant global public health problem. Hyperinfection syndrome occurs in immunocompromised hosts and is associated with chronic steroid therapy. If unrecognized, it is associated with significant morbidity and mortality. Available regimens for the treatment of S. stercoralis in humans include oral agents and infrequently subcutaneous formulations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
